Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
April 23, 2024 13:42 ET
|
Novartis Pharma AG
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patients Gastroenteropancreatic...
Transaction in Own Shares
April 23, 2024 13:37 ET
|
Shell plc
Transaction in Own Shares 23 April, 2024 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 23 April 2024 it purchased the following number of Shares for cancellation. ...
Niðurstöður viðbótarútgáfu - RIKB 27 0415
April 23, 2024 11:31 ET
|
Ríkissjóður Íslands - Lánamál ríkisins
Í tengslum við útboð sem haldið var 19. apríl stóð aðalmiðlurum til boða, samkvæmt 6. grein í almennum útboðsskilmálum ríkisbréfa, að kaupa 10% af andvirði þess sem selt var í útboðinu á söluverði...
Results of additional issuance - RIKB 27 0415
April 23, 2024 11:31 ET
|
The Republic of Iceland – Government Debt Management
As stated in paragraph 6 in General Terms of Auction for Treasury bonds, the Government Debt Management offered the equivalent of 10% of the nominal value sold in the auction 19. April, at the price...
BASF and University of California, Berkeley, celebrate their successful 10-year collaboration
April 23, 2024 10:00 ET
|
BASF Corporation
California Research Alliance (CARA) has expanded to 11 California universities and launched 117 projects advancing technologies addressing key sustainability challenges in the USACARA has fostered 94...
Middlefield Canadian Income PCC: Net Asset Value(s)
April 23, 2024 09:21 ET
|
Middlefield Canadian Income PCC
Middlefield Canadian Income PCC Net Asset Value Middlefield Canadian Income PCC Middlefield Canadian Income - GBP PC (a protected cell company incorporated in Jersey with registration number...
Form 8.3 - Mattioli Woods
April 23, 2024 08:57 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Form 8.3 - Hipgnosis Songs Fund Limited
April 23, 2024 08:50 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Form 8.3 - GCP Asset Backed Income Fund Limited
April 23, 2024 08:08 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Form 8.3 - Balanced Commercial Property Trust Limited
April 23, 2024 08:05 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...